Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders

European Journal of Pharmacology

Volumn 722, Issue 1, 2014, Pages 79-94

  Bashashati, Mohammad ^a   McCallum, Richard W ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cyclic vomiting syndrome; Nausea; Physiopathology; Treatment; Vomiting

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIMIGRAINE AGENT; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; CYCLIZINE; DIPHENHYDRAMINE; DOMPERIDONE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; ENDOCANNABINOID; GHRELIN; HISTAMINE; LORAZEPAM; METOCLOPRAMIDE; MOTILIN; NEUROKININ 1 RECEPTOR ANTAGONIST; OPIATE; PHENOBARBITAL; PROPRANOLOL; SEROTONIN; SUBSTANCE P; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VANILLOID RECEPTOR 1;

ADRENERGIC SYSTEM; BRAIN STEM; CHRONIC DISEASE; CYCLIC VOMITING SYNDROME; DYSPEPSIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IDIOPATHIC DISEASE; INTESTINE PSEUDOOBSTRUCTION; MITOCHONDRION; NAUSEA AND VOMITING; NEUROCHEMISTRY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STOMACH PARESIS; VOMITING;

CYCLIC VOMITING SYNDROME; NAUSEA; PHYSIOPATHOLOGY; TREATMENT; VOMITING;

ANIMALS; ANTIEMETICS; GASTROINTESTINAL DISEASES; HUMANS; NAUSEA; NEUROCHEMISTRY; VOMITING;

EID: 84892839586     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.09.075     Document Type: Review

References (192)

1. R. Abalo, G. Vera, A.E. Lopez-Perez, M. Martinez-Villaluenga, and M.I. Martin-Fontelles The gastrointestinal pharmacology of cannabinoids: focus on motility Pharmacology 90 2012 1 10
2. T.L. Abell, K.A. Adams, R.G. Boles, A. Bousvaros, S.K. Chong, D.R. Fleisher, W.L. Hasler, P.E. Hyman, R.M. Issenman, B.U. Li, S.L. Linder, E.A. Mayer, R.W. McCallum, K. Olden, H.P. Parkman, C.D. Rudolph, Y. Tache, S. Tarbell, and N. Vakil Cyclic vomiting syndrome in adults Neurogastroenterol. Motil. 20 2008 269 284 (Pubitemid 351441737)
3. D.W. Adelson, H.P. Kosoyan, Y. Wang, J.Z. Steinberg, and Y. Tache Gastric vagal efferent inhibition evoked by intravenous CRF is unrelated to simultaneously recorded vagal afferent activity in urethane-anesthetized rats J. Neurophysiol. 97 2007 3004 3014 (Pubitemid 46557728)
4. M. Albayrak, A. Karatas, Y. Demiraran, H. Erman, S. Topuz, I. Biyik, H. Uzun, and M. Erkan Ghrelin, acylated ghrelin, leptin and PYY-3 levels in hyperemesis gravidarum J. Matern. Fetal Neonatal. Med 26 9 2013 866 870
5. R. Alizadeh, S.M. Mireskandari, M. Azarshahin, M.E. Darabi, R. Padmehr, A. Jafarzadeh, and Z. Aghsaee-Fard Oral clonidine premedication reduces nausea and vomiting in children after appendectomy Iran J. Pediatr. 22 2012 399 403
6. K. Ameloot, P. Janssen, E. Scarpellini, R. Vos, W. Boesmans, I. Depoortere, B.P. Vanden, and J. Tack Endocannabinoid control of gastric sensorimotor function in man Aliment. Pharmacol. Ther. 31 2010 1123 1131
7. P.L. Andrews, and P. Bhandari Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret Neuropharmacology 32 1993 799 806 (Pubitemid 23227666)
8. P.L. Andrews, and C.C. Horn Signals for nausea and emesis: implications for models of upper gastrointestinal diseases Auton. Neurosci. 125 2006 100 115
9. P.L. Andrews, and G.J. Sanger Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction Curr. Opin. Pharmacol. 2 2002 650 656 (Pubitemid 35476915)
10. P.L. Andrews, and K.L. Wood Systemic baclofen stimulates gastric motility and secretion via a central action in the rat Br. J. Pharmacol. 89 1986 461 467 (Pubitemid 16008383)
11. A. Antonucci, L. Fronzoni, L. Cogliandro, R.F. Cogliandro, C. Caputo, G.R. De, F. Pallotti, G. Barbara, R. Corinaldesi, and V. Stanghellini Chronic intestinal pseudo-obstruction World J. Gastroenterol. 14 2008 2953 2961
12. C.C. Apfel, K. Zhang, E. George, S. Shi, L. Jalota, C. Hornuss, K.E. Fero, F. Heidrich, J.V. Pergolizzi, O.S. Cakmakkaya, and P. Kranke Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis Clin. Ther. 32 2010 1987 2002
13. L. Atkinson, T.F. Batten, and J. Deuchars P2X(2) receptor immunoreactivity in the dorsal vagal complex and area postrema of the rat Neuroscience 99 2000 683 696
14. F. Barreau, L. Ferrier, J. Fioramonti, and L. Bueno New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models Pediatr. Res. 62 2007 240 245 (Pubitemid 47301468)
15. M. Bashashati, N. Rezaei, C.N. Andrews, C.Q. Chen, N.E. Daryani, K.A. Sharkey, and M.A. Storr Cytokines and irritable bowel syndrome: where do we stand? Cytokine 57 2012 201 209
16. D.B. Beleslin, and S.K. Krstic Further studies on nicotine-induced emesis: nicotinic mediation in area postrema Physiol. Behav. 39 1987 681 686 (Pubitemid 17064396)
17. L.P. Bityutskiy, I. Soykan, and R.W. McCallum Viral gastroparesis: a subgroup of idiopathic gastroparesis - clinical characteristics and long-term outcomes Am. J. Gastroenterol. 92 1997 1501 1504
18. R.G. Boles, E.A. Zaki, T. Lavenbarg, R. Hejazi, P. Foran, J. Freeborn, S. Trilokekar, and R. McCallum Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A Neurogastroenterol. Motil. 21 2009 936 (e72)
19. R. Brun, and B. Kuo Functional dyspepsia Ther. Adv. Gastroenterol. 3 2010 145 164
20. L. Bueno Neuroimmune alterations of ENS functioning Gut 47 Suppl 4 2000 iv63 iv65
21. M. Camilleri, P. Carlson, A.R. Zinsmeister, S. McKinzie, I. Busciglio, D. Burton, E.A. Zaki, and R.G. Boles Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders Am. J. Physiol. Gastrointest. Liver Physiol. 296 2009 G510 G516
22. D.O. Carpenter, D.B. Briggs, and N. Strominger Responses of neurons of canine area postrema to neurotransmitters and peptides Cell. Mol. Neurobiol. 3 1983 113 126 (Pubitemid 14087274)
23. T.C. Chelimsky, and G.G. Chelimsky Autonomic abnormalities in cyclic vomiting syndrome J. Pediatr. Gastroenterol. Nutr. 44 2007 326 330 (Pubitemid 46673379)
24. K.M. Chu, M.P. Ngan, M.K. Wai, C.K. Yeung, P.L. Andrews, S.N. Percie du, G. Lin, and J.A. Rudd Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret Toxicol. Lett. 192 2010 402 407
25. N.L. Cluny, V.K. Vemuri, A.P. Chambers, C.L. Limebeer, H. Bedard, J.T. Wood, B. Lutz, A. Zimmer, L.A. Parker, A. Makriyannis, and K.A. Sharkey A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents Br. J. Pharmacol. 161 2010 629 642
26. S.M. Collins, and P. Bercik The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease Gastroenterology 136 2009 2003 2014
27. S.M. Collins, E. Denou, E.F. Verdu, and P. Bercik The putative role of the intestinal microbiota in the irritable bowel syndrome Dig. Liver Dis. 41 2009 850 853
28. D.N. Cortright, and A. Szallasi Biochemical pharmacology of the vanilloid receptor TRPV1. An update Eur. J. Biochem. 271 2004 1814 1819 (Pubitemid 38657335)
29. N.A. Darmani Cannabinoid-induced hyperemesis: a conundrum-from clinical recognition to basic science mechanisms Pharmaceuticals 3 2010 2163 2177
30. N.A. Darmani, S. Chebolu, B. Amos, and T. Alkam Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva) Pharmacol. Biochem. Behav. 99 2011 573 579
31. N.A. Darmani, and A.P. Ray Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting Chem. Rev. 109 2009 3158 3199
32. N.B. Dass, M. Munonyara, A.K. Bassil, G.J. Hervieu, S. Osbourne, S. Corcoran, M. Morgan, and G.J. Sanger Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin Neuroscience 120 2003 443 453 (Pubitemid 37288779)
33. M. Dauri, S. Faria, A. Gatti, L. Celidonio, R. Carpenedo, and A.F. Sabato Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences Curr. Drug Targets 10 2009 716 733
34. A.P. Davenport, T.I. Bonner, S.M. Foord, A.J. Harmar, R.R. Neubig, J.P. Pin, M. Spedding, M. Kojima, and K. Kangawa International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function Pharmacol. Rev. 57 2005 541 546 (Pubitemid 43036440)
35. M. Davies The role of GABAA receptors in mediating the effects of alcohol in the central nervous system J. Psychiatry Neurosci. 28 2003 263 274 (Pubitemid 37158025)
36. B. De Smit, A. Mitselos, and I. Depoortere Motilin and ghrelin as prokinetic drug targets Pharmacol. Ther. 123 2009 207 223
37. A. Didier, J. Dupont, and Y. Cazals GABA immunoreactivity of calyceal nerve endings in the vestibular system of the guinea pig Cell Tissue Res. 260 1990 415 419 (Pubitemid 20138450)
38. P. Diemunsch, G.P. Joshi, and J.F. Brichant Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting Br. J. Anaesth. 103 2009 7 13
39. G.J. Dockray Cholecystokinin and gut-brain signalling Regul. Pept. 155 2009 6 10
40. L.V. dos Santos, F.H. Souza, A.T. Brunetto, A.D. Sasse, and J.P. da Silveira Nogueira Lima Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review J. Natl. Cancer Inst. 104 2012 1280 1292
41. A. Dowson, K. Ball, and D. Haworth Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study Curr. Med. Res. Opin. 16 2000 190 197 (Pubitemid 32054835)
42. M. Duncan, J.S. Davison, and K.A. Sharkey Review article: endocannabinoids and their receptors in the enteric nervous system Aliment. Pharmacol. Ther. 22 2005 667 683 (Pubitemid 41475329)
43. M. El-Salhy, and J. Rauma Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with type 1 diabetes Mol. Med. Rep. 2 2009 893 896
44. S. Emerenziani, and D. Sifrim Gastroesophageal reflux and gastric emptying, revisited Curr. Gastroenterol. Rep. 7 2005 190 195 (Pubitemid 40916398)
45. T. Endo, M. Minami, M. Hirafuji, T. Ogawa, K. Akita, M. Nemoto, H. Saito, M. Yoshioka, and S.H. Parvez Neurochemistry and neuropharmacology of emesis - the role of serotonin Toxicology 153 2000 189 201
46. E. Engelman, and F. Cateloy Efficacy and safety of perioperative pregabalin for post-operative pain: a meta-analysis of randomized-controlled trials Acta Anaesthesiol. Scand. 55 2011 927 943
47. Z.S. Ercan, and R.K. Turker Histamine receptors in the isolated rat stomach fundus and rabbit aortic strips Pharmacology 15 1977 118 126 (Pubitemid 8062629)
48. T. Esfandyari, M. Camilleri, I. Ferber, D. Burton, K. Baxter, and A.R. Zinsmeister Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study Neurogastroenterol. Motil. 18 2006 831 838 (Pubitemid 44201169)
49. K.M. Fock Functional dyspepsia, H. pylori and post infectious FD J. Gastroenterol. Hepatol. 26 Suppl 3 2011 39 41
50. M. Fujimiya, K. Ataka, A. Asakawa, C.Y. Chen, I. Kato, and A. Inui Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides Digestion 85 2012 90 94
51. K. Fujino, A. Inui, A. Asakawa, N. Kihara, M. Fujimura, and M. Fujimiya Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats J. Physiol. 550 2003 227 240 (Pubitemid 36869283)
52. J.B. Furness, B. Hunne, N. Matsuda, L. Yin, D. Russo, I. Kato, M. Fujimiya, M. Patterson, J. McLeod, Z.B. Andrews, and R. Bron Investigation of the presence of ghrelin in the central nervous system of the rat and mouse Neuroscience 193 2011 1 9
53. J.B. Furness, W.A. Kunze, and N. Clerc Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses Am. J. Physiol. 277 1999 G922 G928
54. S. Gallas, M.H. Sinno, N. Boukhettala, M. Coeffier, N. Dourmap, G. Gourcerol, P. Ducrotte, P. Dechelotte, A.M. Leroi, and S.O. Fetissov Gastric electrical stimulation increases ghrelin production and inhibits catecholaminergic brainstem neurons in rats Eur. J. Neurosci. 33 2011 276 284
55. J.A. Galli, R.A. Sawaya, and F.K. Friedenberg Cannabinoid hyperemesis syndrome Curr. Drug Abuse Rev. 4 2011 241 249
56. J.J. Galligan Ligand-gated ion channels in the enteric nervous system Neurogastroenterol. Motil. 14 2002 611 623 (Pubitemid 35472013)
57. J.J. Galligan, and S. Vanner Basic and clinical pharmacology of new motility promoting agents Neurogastroenterol. Motil. 17 2005 643 653 (Pubitemid 41400712)
58. E. George, C. Hornuss, and C.C. Apfel Neurokinin-1 and novel serotonin antagonists for postoperative and postdischarge nausea and vomiting Curr. Opin. Anaesthesiol. 23 2010 714 721
59. P. Geppetti, and M. Trevisani Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function Br. J. Pharmacol. 141 2004 1313 1320 (Pubitemid 38638820)
60. M.D. Gershon, and J. Tack The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 132 2007 397 414 (Pubitemid 46127672)
61. R. Gokhale, P.R. Huttenlocher, L. Brady, and B.S. Kirschner Use of barbiturates in the treatment of cyclic vomiting during childhood J. Pediatr. Gastroenterol. Nutr. 25 1997 64 67 (Pubitemid 27284287)
62. J.F. Golding, and M.A. Gresty Motion sickness Curr. Opin. Neurol. 18 2005 29 34 (Pubitemid 40270262)
63. J. Golembiewski, and S. Tokumaru Pharmacological prophylaxis and management of adult postoperative/postdischarge nausea and vomiting J. Perianesth. Nurs. 21 2006 385 397 (Pubitemid 44880820)
64. S.M. Grunberg Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis Ann. Oncol. 18 2007 233 240 (Pubitemid 46323087)
65. B.D. Gulbransen, M. Bashashati, S.A. Hirota, X. Gui, J.A. Roberts, J.A. MacDonald, D.A. Muruve, D.M. McKay, P.L. Beck, G.M. Mawe, R.J. Thompson, and K.A. Sharkey Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis Nat. Med. 18 2012 600 604
66. P. Gupta, J. Khanna, A.K. Mitramustafi, and V.K. Bhartia Role of pre-operative dexamethasone as prophylaxis for postoperative nausea and vomiting in laparoscopic surgery J. Minim. Access Surg. 2 2006 12 15 (Pubitemid 43814622)
67. H.L. Haas, O.A. Sergeeva, and O. Selbach Histamine in the nervous system Physiol. Rev. 88 2008 1183 1241
68. R. Hargreaves, J.C. Ferreira, D. Hughes, J. Brands, J. Hale, B. Mattson, and S. Mills Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting Ann. N.Y. Acad. Sci. 1222 2011 40 48
69. W.L. Hasler Gastroparesis: pathogenesis, diagnosis and management Nat. Rev. Gastroenterol. Hepatol. 8 2011 438 453
70. W.L. Hasler Gastroparesis Curr. Opin. Gastroenterol. 28 2012 621 628
71. W.L. Hasler, and W.D. Chey Nausea and vomiting Gastroenterology 125 2003 1860 1867 (Pubitemid 37500449)
72. T. Hattori Rikkunshito and ghrelin Int. J. Pept. 2010 2010
73. S.C. Heinrichs, J. Lapsansky, T.W. Lovenberg, E.B. De Souza, and D.T. Chalmers Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior Regul. Pept. 71 1997 15 21 (Pubitemid 27374934)
74. R.A. Hejazi, T.H. Lavenbarg, and R.W. McCallum Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome Neurogastroenterol. Motil. 22 1298-302 2010 e338
75. R.A. Hejazi, T.H. Lavenbarg, and R.W. McCallum Elevated serum ghrelin levels in adult patients with cyclic vomiting syndrome Am. J. Gastroenterol. 106 2011 1858 1859
76. R.A. Hejazi, T.H. Lavenbarg, M. Pasnoor, M. Dimachkie, P. Foran, L. Herbelin, and R.W. McCallum Autonomic nerve function in adult patients with cyclic vomiting syndrome Neurogastroenterol. Motil. 23 2011 439 443
77. R.A. Hejazi, and R.W. McCallum Review article: cyclic vomiting syndrome in adults - rediscovering and redefining an old entity Aliment. Pharmacol. Ther. 34 2011 263 273
78. R. Herranz Cholecystokinin antagonists: pharmacological and therapeutic potential Med. Res. Rev. 23 2003 559 605 (Pubitemid 37034145)
79. Hillard, C.J., Raff, H., Venkatesan, T., 2013. Circulating Endocannabinoids in Cyclic Vomiting Syndrome. ICRS Meeting, Vancouver, BC, Canada, June 21-26. Ref Type: Abstract.
80. M. Hirano, Y. Nishigaki, and R. Marti Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes Neurologist 10 2004 8 17 (Pubitemid 38140835)
81. Y. Hiura, S. Takiguchi, K. Yamamoto, Y. Kurokawa, M. Yamasaki, K. Nakajima, H. Miyata, Y. Fujiwara, M. Mori, and Y. Doki Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients Int. J. Clin. Oncol. 17 2012 316 323
82. Y. Hiura, S. Takiguchi, K. Yamamoto, T. Takahashi, Y. Kurokawa, M. Yamasaki, K. Nakajima, H. Miyata, Y. Fujiwara, M. Mori, K. Kangawa, and Y. Doki Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study Cancer 118 2012 4785 4794
83. P.J. Hornby Central neurocircuitry associated with emesis Am. J. Med. 111 Suppl 8A 2001 106S 112S (Pubitemid 34032001)
84. D. Ionescu, C. Badescu, and I. Acalovschi Nicotine patch for the prevention of postoperative nausea and vomiting: a prospective randomised trial Clin. Drug Invest. 27 2007 559 564 (Pubitemid 47124097)
85. A.A. Izzo, and K.A. Sharkey Cannabinoids and the gut: new developments and emerging concepts Pharmacol. Ther. 126 2010 21 38
86. F.A. Javid, D.C. Bulmer, J. Broad, Q. Aziz, G.E. Dukes, and G.J. Sanger Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors Eur. J. Pharmacol. 699 2013 48 54
87. Johnston, K.D., Lu, Z., Rudd, J.A., 2013. Looking beyond 5-HT(3) receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting. Eur. J. Pharmacol. pii: S0014-2999(13)00758-9. 10.1016/j.ejphar.2013.10.014
88. K.L. Jones, J.M. Wishart, M.K. Berry, J.L. Abitbol, and M. Horowitz Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis Aliment. Pharmacol. Ther. 14 2000 937 943 (Pubitemid 30446906)
89. K. Jordan, C. Kasper, and H.J. Schmoll Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment Eur. J. Cancer 41 2005 199 205 (Pubitemid 40126951)
90. Y. Kawahito, H. Sano, M. Kawata, K. Yuri, S. Mukai, Y. Yamamura, H. Kato, G.P. Chrousos, R.L. Wilder, and M. Kondo Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon Gastroenterology 106 1994 859 865 (Pubitemid 24109270)
91. P.W. Keeley Nausea and vomiting Medicine 39 2011 648 650
92. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660 (Pubitemid 129516334)
93. T. Kondo, K. Obata, K. Miyoshi, J. Sakurai, J. Tanaka, H. Miwa, and K. Noguchi Transient receptor potential A1 mediates gastric distention-induced visceral pain in rats Gut 58 2009 1342 1352
94. T. Kondo, T. Oshima, K. Obata, J. Sakurai, C.H. Knowles, T. Matsumoto, K. Noguchi, and H. Miwa Role of transient receptor potential A1 in gastric nociception Digestion 82 2010 150 155
95. A. Krantis GABA in the mammalian enteric nervous system News Physiol. Sci. 15 2000 284 290 (Pubitemid 33205098)
96. M. Larauche, A. Mulak, and Y. Tache Stress and visceral pain: from animal models to clinical therapies Exp. Neurol. 233 2012 49 67
97. A. Lecci, A. Capriati, and C.A. Maggi Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome Br. J. Pharmacol. 141 2004 1249 1263 (Pubitemid 38638814)
98. A. Lecci, M. Tramontana, S. Giuliani, and C.A. Maggi Role of tachykinin NK1 and NK2 receptors on colonic motility in anesthetized rats: effect of agonists Can. J. Physiol. Pharmacol. 75 1997 582 586 (Pubitemid 27458640)
99. L.Y. Lee, L. Abbott, B. Mahlangu, S.J. Moodie, and S. Anderson The management of cyclic vomiting syndrome: a systematic review Eur. J. Gastroenterol. Hepatol. 24 2012 1001 1006
100. S.B. LeGrand, and D. Walsh Scopolamine for cancer-related nausea and vomiting J. Pain Symptom Manage. 40 2010 136 141
101. Lexi-Comp Online.(n.d.)., 2013. Retrieved from: 〈http: //WWW.Online.Lexi.comâŒ. http://online.lexi.com. Lexi-Comp, Inc. Ref Type: Electronic Citation.
102. B.U. Li, F. Lefevre, G.G. Chelimsky, R.G. Boles, S.P. Nelson, D.W. Lewis, S.L. Linder, R.M. Issenman, and C.D. Rudolph North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome J. Pediatr. Gastroenterol. Nutr. 47 2008 379 393
103. N. Liao, Z.K. Xie, J. Huang, and Z.F. Xie Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: a meta-analysis Gene 517 2013 179 183
104. K.J. Lindley, and P.L. Andrews Pathogenesis and treatment of cyclical vomiting J. Pediatr. Gastroenterol. Nutr. 41 Suppl 1 2005 S38 S40
105. S. Liu, and J.D. wood Neurobiology of corticotropin-releasing factor in the enteric nervous system during stress L.P. Filaretova, K. Takeuchi, Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal tract: Mechanisms, Prevention, and Treatment 2012 Karger Basel 115 123
106. A.E. Lomax, P.P. Bertrand, and J.B. Furness Identification of the populations of enteric neurons that have NK1 tachykinin receptors in the guinea-pig small intestine Cell Tissue Res. 294 1998 27 33 (Pubitemid 28442279)
107. A. Luckey, E. Livingston, and Y. Tache Mechanisms and treatment of postoperative ileus Arch. Surg. 138 2003 206 214 (Pubitemid 36216289)
108. E.A. MacGregor, M. Wilkinson, and K. Bancroft Domperidone plus paracetamol in the treatment of migraine Cephalalgia 13 1993 124 127 (Pubitemid 23116124)
109. K. Maganti, K. Onyemere, and M.P. Jones Oral erythromycin and symptomatic relief of gastroparesis: a systematic review Am. J. Gastroenterol. 98 2003 259 263 (Pubitemid 36232369)
110. C.A. Maggi, R.M. Catalioto, M. Criscuoli, P. Cucchi, S. Giuliani, A. Lecci, A. Lippi, S. Meini, R. Patacchini, A.R. Renzetti, P. Santicioli, M. Tramontana, V. Zagorodnyuk, and A. Giachetti Tachykinin receptors and intestinal motility Can. J. Physiol. Pharmacol. 75 1997 696 703 (Pubitemid 27458659)
111. S.B. Marcus, S.M. Agiabe-Willia, D. Grigoriadis, and Y. Tache Corticotropin-releasing factor (CRF) levels are elevated during episodes of cyclic vomiting syndrome Gastroenterology 130 2006 A4
112. E.L. Marderstein, and C.P. Delaney Management of postoperative ileus: focus on alvimopan Ther. Clin. Risk Manage. 4 2008 965 973
113. Y. Masuda, T. Tanaka, N. Inomata, N. Ohnuma, S. Tanaka, Z. Itoh, H. Hosoda, M. Kojima, and K. Kangawa Ghrelin stimulates gastric acid secretion and motility in rats Biochem. Biophys. Res. Commun. 276 2000 905 908
114. E.A. Mayer Gut feelings: the emerging biology of gut-brain communication Nat. Rev. Neurosci. 12 2011 453 466
115. R.W. McCallum, and O. Cynshi Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study Aliment. Pharmacol. Ther. 26 2007 1121 1130 (Pubitemid 47480960)
116. R.W. McCallum, and O. Cynshi Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial Aliment. Pharmacol. Ther. 26 2007 107 116 (Pubitemid 46889836)
117. H. Mihara, A. Boudaka, K. Shibasaki, A. Yamanaka, T. Sugiyama, and M. Tominaga Involvement of TRPV2 activation in intestinal movement through nitric oxide production in mice J. Neurosci. 30 2010 16536 16544
118. A.D. Miller Central mechanisms of vomiting Dig. Dis. Sci. 44 1999 39S 43S (Pubitemid 29450790)
119. T. Naftali, R. Yishai, T. Zangen, and A. Levine Post-infectious gastroparesis: clinical and electerogastrographic aspects J. Gastroenterol. Hepatol. 22 2007 1423 1428 (Pubitemid 47274574)
120. Y. Nagakura, S. Kakimoto, and N. Matsuoka Purinergic P2X receptor activation induces emetic responses in ferrets and Suncus murinus (house musk shrews) Br. J. Pharmacol. 152 2007 464 470 (Pubitemid 47585045)
121. J.R. Niebyl Clinical practice. Nausea and vomiting in pregnancy N. Engl. J. Med. 363 2010 1544 1550
122. K. Nozawa, E. Kawabata-Shoda, H. Doihara, R. Kojima, H. Okada, S. Mochizuki, Y. Sano, K. Inamura, H. Matsushime, T. Koizumi, T. Yokoyama, and H. Ito TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells Proc. Natl. Acad. Sci. USA 106 2009 3408 3413
123. T. Ohno, M. Yanai, H. Ando, Y. Toyomasu, A. Ogawa, H. Morita, K. Ogata, E. Mochiki, T. Asao, and H. Kuwano Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans Clin. Exp. Gastroenterol. 4 2011 291 296
124. K.W. Olden, and P. Chepyala Functional nausea and vomiting Nat. Clin. Pract. Gastroenterol. Hepatol. 5 2008 202 208 (Pubitemid 351516737)
125. A.S. Oruc, I. Mert, M. Akturk, E. Aslan, B. Polat, U. Buyukkagnici, and N. Danisman Ghrelin and motilin levels in hyperemesis gravidarum Arch. Gynecol. Obstet 2013
126. K.V. Panganamamula, and H.P. Parkman Chronic intestinal pseudo-obstruction Curr. Treat. Options Gastroenterol. 8 2005 3 11 (Pubitemid 40268330)
127. N. Pareek, D.R. Fleisher, and T. Abell Cyclic vomiting syndrome: what a gastroenterologist needs to know Am. J. Gastroenterol. 102 2007 2832 2840 (Pubitemid 350182390)
128. P.J. Pasricha, M.M. Schuster, C.D. Saudek, G. Wand, and W.J. Ravich Cyclic vomiting: association with multiple homeostatic abnormalities and response to ketorolac Am. J. Gastroenterol. 91 1996 2228 2232 (Pubitemid 26338986)
129. L.M. Patterson, H. Zheng, S.M. Ward, and H.R. Berthoud Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract Cell Tissue Res. 311 2003 277 287 (Pubitemid 36459667)
130. N.W. Pedigo Jr., and K.R. Brizzee Muscarinic cholinergic receptors in area postrema and brainstem areas regulating emesis Brain Res. Bull. 14 1985 169 177 (Pubitemid 15124312)
131. T.L. Peeters Central and peripheral mechanisms by which ghrelin regulates gut motility J. Physiol. Pharmacol. 54 Suppl 4 2003 95 103
132. S.J. Peroutka Migraine: a chronic sympathetic nervous system disorder Headache 44 2004 53 64 (Pubitemid 38116663)
133. D.A. Perwitasari, H. Gelderblom, J. Atthobari, M. Mustofa, I. Dwiprahasto, J.W. Nortier, and H.J. Guchelaar Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics Int. J. Clin. Pharm. 33 2011 33 43
134. S. Petrosino, and V. Di Marzo FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels Curr. Opin. Investig. Drugs 11 2010 51 62
135. A.N. Pilichiewicz, K.L. Feltrin, M. Horowitz, G. Holtmann, J.M. Wishart, K.L. Jones, N.J. Talley, and C. Feinle-Bisset Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY Am. J. Gastroenterol. 103 2008 2613 2623
136. B.J. Pleuvry Physiology and pharmacology of nausea and vomiting Anaesth. Intensive Care Med. 13 2012 598 602
137. A.L. Portbury, J.B. Furness, H.M. Young, B.R. Southwell, and S.R. Vigna Localisation of NK1 receptor immunoreactivity to neurons and interstitial cells of the guinea-pig gastrointestinal tract J. Comp. Neurol. 367 1996 342 351 (Pubitemid 26107123)
138. A.O. Quartero, N.J. de Wit, A.C. Lodder, M.E. Numans, A.J. Smout, and A.W. Hoes Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis Dig. Dis. Sci. 43 1998 2028 2033
139. E.M. Quigley, W.L. Hasler, and H.P. Parkman AGA technical review on nausea and vomiting Gastroenterology 120 2001 263 286 (Pubitemid 32061891)
140. K. Racke, H. Schworer, and H. Kilbinger Effects of the benzodiazepine receptor agonist midazolam and antagonist flumazenil on 5-hydroxytryptamine release from guinea-pig intestine in vitro. Indirect support for a "natural" benzodiazepine-like substance in the intestine Naunyn Schmiedebergs Arch. Pharmacol. 341 1990 1 7 (Pubitemid 20062187)
141. H. Rashed, T.L. Abell, B.O. Familoni, and S. Cardoso Autonomic function in cyclic vomiting syndrome and classic migraine Dig. Dis. Sci. 44 1999 74S 78S (Pubitemid 29450795)
142. S.C. Reddymasu, and R.W. McCallum Pharmacotherapy of gastroparesis Expert. Opin. Pharmacother. 10 2009 469 484
143. S.C. Reddymasu, I. Soykan, and R.W. McCallum Domperidone: review of pharmacology and clinical applications in gastroenterology Am. J. Gastroenterol. 102 2007 2036 2045 (Pubitemid 47301500)
144. E. Rey, R.S. Choung, C.D. Schleck, A.R. Zinsmeister, N.J. Talley, and G.R. Locke III Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg" J. Neurogastroenterol. Motil. 18 2012 34 42
145. J.A. Roberts, M.K. Lukewich, K.A. Sharkey, J.B. Furness, G.M. Mawe, and A.E. Lomax The roles of purinergic signaling during gastrointestinal inflammation Curr. Opin. Pharmacol. 12 2012 659 666
146. A. Russo, J.E. Stevens, N. Giles, G. Krause, D.G. O'Donovan, M. Horowitz, and K.L. Jones Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis Aliment. Pharmacol. Ther. 20 2004 333 338 (Pubitemid 39062136)
147. C.D. Salpietro, S. Briuglia, M.V. Merlino, B.C. Di, and L. Rigoli A mitochondrial DNA mutation (A3243G mtDNA) in a family with cyclic vomiting Eur. J. Pediatr. 162 2003 727 728 (Pubitemid 37255511)
148. L.E. Sander, A. Lorentz, G. Sellge, M. Coeffier, M. Neipp, T. Veres, T. Frieling, P.N. Meier, M.P. Manns, and S.C. Bischoff Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract Gut 55 2006 498 504
149. G.J. Sanger, and P.L. Andrews Treatment of nausea and vomiting: gaps in our knowledge Auton. Neurosci. 129 2006 3 16 (Pubitemid 44472635)
150. G.J. Sanger, Y. Wang, A. Hobson, and J. Broad Motilin: toward a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists Br. J. Pharmacol 2012 http://dx.doi.org/10.1111/bph. 12075
151. K. Schulze-Delrieu Drug therapy. Metoclopramide N. Engl. J. Med. 305 1981 28 33
152. K. Scorza, A. Williams, J.D. Phillips, and J. Shaw Evaluation of nausea and vomiting Am. Fam. Physician 76 2007 76 84 (Pubitemid 47036289)
153. J.N. Sengupta Visceral pain: the neurophysiological mechanism Handb. Exp. Pharmacol. 2009 31 74
154. K.A. Sharkey, L. Cristino, L.D. Oland, S. Van, K. Starowicz, Q.J. Pittman, V. Guglielmotti, J.S. Davison, and V. Di Marzo Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret Eur. J. Neurosci. 25 2007 2773 2782 (Pubitemid 46888837)
155. Sharkey, K.A., Darmani, N.A., Parker, L.A., 2013. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur. J. Pharmacol. pii: S0014-2999(13)00753-X. http://dx.doi.org/10.1016/j.ejphar.2013.09.068.
156. S.S. Sim, S.H. Yoon, S.J. Hahn, Y.H. Jo, C.C. Kim, and M.S. Kim The action of histamine on the isolated stomach muscle of the cat Scand. J. Gastroenterol. 24 1989 961 968
157. H.S. Smith, E.J. Smith, and A.R. Smith Pathophysiology of nausea and vomiting in palliative medicine Ann. Palliat. Med. 1 2012 87 93
158. Smith, H.S., Laufer, A., 2013. Opioid induced nausea and vomiting. Eur. J. Pharmacol. pii: S0014-2999(13)00771-1. http://dx.doi.org/10.1016/j.ejphar. 2013.09.074.
159. H.S. Smith, J.M. Smith, and P. Seidner Opioid-induced nausea and vomiting Ann. Palliat. Med. 1 2012 121 129
160. M. Sobczak, M. Salaga, M.A. Storr, and J. Fichna Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives J. Gastroenterol 2013 10.1007/s00535-013-0753-x
161. E. Soto, and R. Vega Neuropharmacology of vestibular system disorders Curr. Neuropharmacol. 8 2010 26 40
162. Spinks,A., Wasiak, J., 2011. Scopolamine (hyoscine) for Preventing and
163. J. Strydom Opioid antagonists and their therapeutic role in anaesthesia and chronic pain management SAJAA 13 2007 61 68
164. T. Suzuki, A. Nurrochmad, M. Ozaki, J. Khotib, A. Nakamura, S. Imai, M. Shibasaki, Y. Yajima, and M. Narita Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects Neuropharmacology 49 2005 1121 1131 (Pubitemid 41608636)
165. Y. Tache Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis Dig. Dis. Sci. 44 1999 79S 86S (Pubitemid 29450796)
166. Y. Tache, and B. Bonaz Corticotropin-releasing factor receptors and stress-related alterations of gut motor function J. Clin. Invest. 117 2007 33 40 (Pubitemid 46048447)
167. Y. Tache, C. Kiank, and A. Stengel A role for corticotropin-releasing factor in functional gastrointestinal disorders Curr. Gastroenterol. Rep. 11 2009 270 277
168. J. Tack, I. Depoortere, R. Bisschops, K. Verbeke, J. Janssens, and T. Peeters Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis Aliment. Pharmacol. Ther. 22 2005 847 853 (Pubitemid 41568544)
169. J. Tack, and P. Janssen Emerging drugs for functional dyspepsia Expert Opin. Emerg. Drugs 16 2011 283 292
170. J. Tack, P. Janssen, T. Masaoka, R. Farre, and O.L. Van Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia Clin. Gastroenterol. Hepatol. 10 2012 1239 1245
171. J. Tack, N.J. Talley, M. Camilleri, G. Holtmann, P. Hu, J.R. Malagelada, and V. Stanghellini Functional gastroduodenal disorders Gastroenterology 130 2006 1466 1479
172. A. Taheri, M.A. Javadimanesh, and H. Ashraf The effect of oral clonidine premedication on nausea and vomiting after ear surgery Middle East J. Anesthesiol. 20 2010 691 694
173. N.J. Talley Functional nausea and vomiting Aust. Fam. Physician 36 2007 694 697
174. N.J. Talley, M. Verlinden, D.J. Geenen, R.B. Hogan, D. Riff, R.W. McCallum, and R.J. Mack Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial Gut 49 2001 395 401 (Pubitemid 32802575)
175. N.J. Talley, M. Verlinden, W. Snape, J.A. Beker, P. Ducrotte, A. Dettmer, H. Brinkhoff, E. Eaker, G. Ohning, P.B. Miner, J.R. Mathias, I. Fumagalli, D. Staessen, and R.J. Mack Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial Aliment. Pharmacol. Ther. 14 2000 1653 1661 (Pubitemid 32011739)
176. A.R. Thorn Not just another case of nausea and vomiting: a review of postinfectious gastroparesis J. Am. Acad. Nurse Pract. 22 2010 125 133
177. B. Todaro Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting J. Natl. Compr. Cancer Netw. 10 2012 487 492
178. T. Uchiyama, and R. Chess-Williams Muscarinic receptor subtypes of the bladder and gastrointestinal tract J. Smooth Muscle Res. 40 2004 237 247 (Pubitemid 40364079)
179. O. Ukkola, E. Ravussin, P. Jacobson, L. Perusse, T. Rankinen, M. Tschop, M.L. Heiman, A.S. Leon, D.C. Rao, J.S. Skinner, J.H. Wilmore, L. Sjostrom, and C. Bouchard Role of ghrelin polymorphisms in obesity based on three different studies Obes. Res. 10 2002 782 791 (Pubitemid 135687519)
180. A. Ukleja Dumping syndrome: pathophysiology and treatment Nutr. Clin. Pract. 20 2005 517 525 (Pubitemid 350042715)
181. J.A. Vanderhoof, R. Young, S.S. Kaufman, and L. Ernst Treatment of cyclic vomiting in childhood with erythromycin J. Pediatr. Gastroenterol. Nutr. 21 Suppl 1 1995 S60 S62
182. P.J. Verhulst, and I. Depoortere Ghrelin's second life: from appetite stimulator to glucose regulator World J. Gastroenterol. 18 2012 3183 3195
183. B. von Mentzer, Y. Murata, I. Ahlstedt, E. Lindstrom, and V. Martinez Functional CRF receptors in BON cells stimulate serotonin release Biochem. Pharmacol. 73 2007 805 813 (Pubitemid 46237613)
184. P.A. Wackym, C.T. Chen, A. Ishiyama, R.M. Pettis, I.A. Lopez, and L. Hoffman Muscarinic acetylcholine receptor subtype mRNAs in the human and rat vestibular periphery Cell Biol. Int. 20 1996 187 192 (Pubitemid 26197510)
185. F. Walberg, and O.P. Ottersen Neuroactive amino acids in the area postrema. An immunocytochemical investigation in rat with some observations in cat and monkey (Macaca fascicularis) Anat. Embryol. (Berl) 185 1992 529 545
186. J.M. Wo, N. Ejskjaer, P.M. Hellstrom, R.A. Malik, J.C. Pezzullo, L. Shaughnessy, P. Charlton, G. Kosutic, and R.W. McCallum Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting - randomised clinical study subset data Aliment. Pharmacol. Ther. 33 2011 679 688
187. J.D. Wood Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies Gut 55 2006 445 447
188. K.L. Wood, J.I. Addae, P.L. Andrews, and T.W. Stone Injection of baclofen into the ventromedial hypothalamus stimulates gastric motility in the rat Neuropharmacology 26 1987 1191 1194 (Pubitemid 17136974)
189. K.L. Wright, M. Duncan, and K.A. Sharkey Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation Br. J. Pharmacol. 153 2008 263 270
190. L. Xu, I. Depoortere, C. Tomasetto, M. Zandecki, M. Tang, J.P. Timmermans, and T.L. Peeters Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus Regul. Pept. 124 2005 119 125 (Pubitemid 39488349)
191. A.B. Young, and D. Chu Distribution of GABAA and GABAB receptors in mammalian brain: potential targets for drug development J. Natl. Cancer Inst. 21 1990 161 167
192. E.A. Zaki, T. Freilinger, T. Klopstock, E.E. Baldwin, K.R. Heisner, K. Adams, M. Dichgans, S. Wagler, and R.G. Boles Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome Cephalalgia 29 2009 719 728